COLDA
Meeting category
Date(s)
7 Sep 2023 - 9 Sep 2023
Program Language
English, French
Location
Dar es Salaam, Tanzania
Meeting type
Hybrid Meeting
Organizer

Conference on Liver Disease in Africa (COLDA) 2023

Related Enduring Materials

Enduring Materials
- parallel sessions
Day 1 - Thursday, 7 September
Opening of the Conference - 10:00
UN - Group of Friends
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
African Union/ African CDC - Growing Portfolio of Hepatitis-Related Activities
Hanna Amanuel Tesfahunei
Africa CDC, Ethiopia
WHO HBV Guidelines - New Directions for Hepatitis B Treatment and Care and Implications for Africa
Philippa Easterbrook, MD, FRCP, MPH, DTM&H
World Health Organization, Switzerland
Barriers to Implementation/Access to Care
Danjuma K. Adda, MPH, FIMS, Dip-IMS
World Hepatitis Alliance (WHA), Nigeria
Session 1: Hepatitis Elimination - Monitoring & Screening (Diagnostics) -
Hepatitis B Genotype
Anna Kramvis, BSc Hons, PhD
Hepatitis Virus Diversity Research Unit / ICE-HBV, South Africa
#1 - Hepatitis B (HBV) Testing and Treatment Policy Assessment in Six African Countries: Examples to Inform HBV Program Scale-up
Lindsey Hiebert
United States
#2 - A Hepatitis B Virus Dual Point-Of-Care Test Strategy to Identify Treatment-Eligible Patients in Africa
Mifta Dellil
Ethiopia
#3 - Time to Initiation of Hepatitis B Treatment Is Reduced With the Use of the Xpert HBV DNA Kit
Hailemichael Desalegn
Ethiopia
#4 - Hepatitis E Virus Detected in Wastewater Samples in South Africa
Bronwyn Roberts
South Africa
Session 2: Clinical Management of Viral Hepatitis -
HCV: Effect of Reinfection on Elimination - Importance of Self Testing
Janvier Serumondo, MD, MPH, MTM
Rwanda Biomedical Centre, Rwanda
Sustainable Access to Diagnostics & Therapeutics for HBV
John Rwegasha, MBChB, MMed, FRCP(Lond), MSc
Muhimbili University of Health Sciences, Tanzania
#5 - Evaluation of Interventions to Improve Timely Hepatitis B Birth Dose Vaccination Coverage Among Infants
Florence Kanu
United States
#6 - Effectiveness of Tenofovir Prophylaxis for the Prevention of Mother-to-child-transmission of Hepatitis B
Serge Ouoba
Japan
#7 - HBeAg and HBV DNA in the Hepatitis B in Africa Collaborative Network (HEPSANET)
Alexander Stockdale
United Kingdom
#8 - Virological Characterization of Treatment Failures and Retreatment Outcomes in Patients Infected With “Unusual” HCV Genotype 1 Subtypes
Erwan Vo Quang
France
#9 - Introducing Sofosbuvir/Velpatasvir+Ribavirin as a Generic Retreatment Regimen for Hepatitis C: A Prospective Cohort Study in Rwanda
Janvier Serumondo
Rwanda
Day 2 - Friday, 8 September
Session 3: Liver Complications - Monitoring -
Management of Complications of Cirrhosis
Eva Justine Uiso, MD, MMED, MSc
Muhimbili National Hospital, Tanzania
A New Player in the Management of Liver Disease in Sub-Saharan Africa: The Tanzania IR Experience
Erick M. Mbuguje, MD
Muhimbili National Hospital, Tanzania
#10 - Molecular Characterization of Hepatitis B Virus Infection in HIV Infected Adults On Antiretroviral Therapy
Lydia Ochieng
Kenya
#11 - Compared to the Wild-Type, the G1862T Mutant of Hepatitis B Virus (HBV) Induces Upregulation of Fibronectin Expression and Wnt/β-catenin Pathway in Vitro
Aurelie Deroubaix
South Africa
Session 4: Liver Complications - Management / Transplantation -
Bilharzia and Viral Hepatitis
Imam Waked, MD, FRCP, FAASLD
National Liver Institute (NLI), Egypt
#12B - Fatty Liver Disease and Its Correlates Among People Living With HIV Attending Care and Treatment Clinic at Temeke Regional Referral Hospital, Dar Es Salaam, Tanzania
Farida Mtonga
Tanzania
#13 - Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Among Adults With Chronic Hepatitis B Infection in the Gambia
Bakary K. Dibba
Gambia
Session 5: Management of Liver Disease - Abstract Driven Lectures -
#15 - Establishing the Hepatitis B and C Prevention and Management program: Malawi’s experience
Wongani Mzumara
Malawi
#16 - Long-Term Outcomes of a Population-Based Cohort of Chronic Hepatitis B (CHB) Patients in West Africa
Gibril Ndow
Gambia
#17 - Implementation of HBV Screening in Kilifi, Kenya: Real World Insights to Inform Clinical Service Development and Translational Studies
Louise Downs
United Kingdom
#18 - Assessment of Hepatocellular Carcinoma Differences in Urban and Rural Africa Through Satellite Imaging Analysis
Jose Debes
United States
#19 - Platelet Count to Spleen Diameter Ratio as a Predictor of Oesophageal Varices in Patients With Liver Cirrhosis at Muhimbili National Hospital Dar Es Salaam, Tanzania
Bakari Absheikh Gillah
Tanzania
Session 7: Multidisciplinary Care For Hepatocellular Carcinoma (HCC): Management Update - 3:50
Hepatocellular Carcinoma - Africa’s Experience
Ashraf Omar, MD, MSc
Cairo University, Egypt
Case Presentation 1 - HCC Tumor Board
Julie Heimbach, MD
Mayo Clinic, United States
Beau Bosko Toskich, MD FSIR
Mayo Clinic, United States
Lewis Roberts, MBChB, PhD, FAASLD
Mayo Clinic, United States
Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center / Weill Medical School at Cornell University, United States
Melissa Goebel, MD
California Pacific Medical Center, United States
Sravana Chennupati, MD
Alta Bates Comprehensive Cancer Center, United States
Session 7: Role of Multidisciplinary Approach in Resource-limited Settings - SOLDA Support Session -
Case Presentation 2 - End stage Liver Disease Clinical Case
Erick M. Mbuguje, MD
Muhimbili National Hospital, Tanzania
Eric Aris, MD, MMed
Rabininsia Memorial Hospital / Aga Khan Hospital, Tanzania
Day 3 - Saturday, 9 September
Session 8: The Hidden Danger of Alcohol and NAFLD in Patients With Viral Hepatitis - EASL Session -
Management of NASH in Patients With Viral Hepatitis
Maria Buti, MD, PhD
Hospital General Universitari Valle Hebron, Spain
Management of Alcohol in Patients With Viral Hepatitis
Aleksander Krag, MD, PhD, MBA
Odense University Hospital / EASL, Denmark
Session 9: Steatotic Liver Disease -
A Global Action Agenda for Turning the Tide on Fatty Liver Disease
Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
University of Cape Town, South Africa
Pediatric steatotic Liver Disease
Manal Hamdy El-Sayed, MD, PhD
Ain Shams University, Egypt
Lifestyle Modifications
Faraja Chiwanga, MD, M.Med, MSc, MSPH
Muhimbili National Hospital - Mloganzila, Tanzania
General
Welcome

The Conference on Liver Disease in Africa (COLDA) 2023 took place in Dar es Salaam, Tanzania as a hybrid meeting from 7-9 September.

Co-organized by SOLDA and Academic Medical Education in close collaboration with regional societies, COLDA 2023 aims at empowering healthcare professionals (HCPs) to diagnose, prevent, treat, and achieve a cure for liver diseases for the benefit of patients in Africa. This being the 6th COLDA, we continue to cultivate a platform that provides a unique opportunity for clinicians, researchers, policymakers, industry representatives, and other healthcare professionals in the African region. Together with support from an international community of experts, they will exchange knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context.

We aspire to provide you with a highly scientific and educational abstract-driven conference consisting of keynote speeches, state-of-the-art lectures, oral and poster abstract presentations, roundtable discussions, and debates with ample time for discussion.

We are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone will have an exceptional opportunity to share and acquire knowledge, and experience a wide spectrum of topics related to liver disease.

Program Chairs 2023
Local Chairs 2023

General Information 

Meeting Objectives
COLDA aims to:

- Gather experts from the African region involved in the research, diagnosis, and treatment of liver diseases in an interactive conference setting;

- Discuss the diagnostic, therapeutic, and preventative efforts of liver disease tailored to regional and local needs, translating best practices into daily practice guidelines and policies;

- Contribute towards hepatitis elimination efforts;

- Leverage on the findings from international studies through the delivery of updates from major meetings that can be applied at the local and regional level to combat liver diseases;

- Facilitate a robust dialogue among participants through interactive networking and a networking reception; and

- Foster new and lasting interdisciplinary partnerships and collaborations among various researchers to improve knowledge sharing with aim of combating liver diseases in Africa.
Learning Objectives
After participating in COLDA, participants will be able to:

- Discuss the epidemiology and treatment of liver disease at an individual and population level;

- Ensure the knowledge and availability of HBV and HCV therapy and their correct usage;

- Discuss evolving modalities of monitoring liver disease and their availability in the African setting; and

- Update on new developments in the investigation of liver disease and their use in an African setting.

Practical Information 

Accommodation
Accommodation is not included in the registration fee.
Badges
All participants are requested to wear the badge at all times during the workshop to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to participants after they have attended the conference and completed the post-meeting survey.
Language
The official conference language will be English. Translation to French will be available.
Enduring Materials
Enduring materials will be available here shortly after the conclusion of the conference.
Disclaimer
The conference is co-organized by Academic Medical Education and SOLDA and the conference secretariat is Virology Education BV. This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference organizer and conference secretariat cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. The conference organizer and conference secretariat disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the conference organizer and conference secretariat do not accept responsibility for any applicable insurances. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official conference sessions. Only the official medical writer appointed by the conference organizer and conference secretariat may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided that the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration

Registration is now closed!

Abstracts

The Abstract Submission Portal is now closed.

Image
COLDA - online participation - Stock photo
Committees
Organizing Committee
Ward, John 2023
John Ward, MD
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

To augment the organizing committee, the following are scientific committee members

  • Mary Afihene, MBChB, FWACP – Kwame Nkrumah University, Ghana 

  • Kosh Agarwal, MD - King’s College Hospital, United Kingdom

  • Bisi Bright, B.Pharm(Hons), MPH, FPCPharm, FPSN, C.Psych - LiveWell Initiative (LWI), Nigeria

  • Nabil Debzi, MD - Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers, Algeria

  • Alice Guingané, MD, MPH - Bogodogo University Hospital Center / University of Montpellier, Burkina Faso / France

  • Kenneth Kabagambe - National Organization for People Living with Hepatitis B, Uganda

  • Olufunmilayo Lesi, MD, MBA, FMCP - World Health Organization, Switzerland

  • Emmanuel Musabeyezu, MD, FCP – King Faisal Hospital, Rwanda

  • Yvonne Nartey, MBChB, MSc, MPhil – Cape Coast Teaching Hospital, Ghana

  • Gibril Ndow, MD – Imperial College London / London School of Hygiene & Tropical Medicine, The Gambia

  • Ashraf Omar, MD, MSc - Cairo University, Egypt

  • John Rwegasha, MBChB, M.MED, FRCP, MSc - Muhimbili National Hospital, Tanzania

  • Edford Sinkala, MD, PhD - University Teaching Hospital / University of Zambia, Zambia

  • Sonjelle Shilton, MPH - Foundation for Innovative New Diagnostics (FIND), Switzerland

  • Mark Sonderup, B Pharm, MBChB, FCP(SA), MMed - University of Cape Town, South Africa

  • Elijah Songok, MD, PhD - Kenya Medical Research Institute, Kenya

  • Christian Tzeuton, MD – Douala Medical School / Société Camerounaise de Gastro-Enterologie, Cameroon

  • Lewis R. Roberts, MBChB, Ph.D -  Mayo Clinic, USA

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Support
Bronze Level
Principal Supporter
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in liver diseases in Africa.
 
This collaboration plays a vital role in both the organizational as well as the scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Brenda Evan at brenda.evan@amededu.com or call +31 30 230 7149
 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, program book, the streaming platform, and our website
  • Digital advertising opportunities 
  • Social media shout-outs
  • Logo on the digital conference bag 
  • Exhibition

 
*Subject to the support level

Endorser
Endorsers
Partners

A 25% discount on the meeting registration fee is offered to the members/employees of our endorsers. Please reach out to your organization for your discount code.

If you would like your organization to endorse COLDA 2023, please contact Magda Sevlidou at magda.sevlidou@amededu.com

Previous Editions
Top-Rated Materials from Previous Editions

The Story of Hepatitis C: Translating Science to Clinical Reality - Harvey J. Alter, MD, MACP

COLDA 2021

Media
COLDA 2023: Press Conference Release in Dar es Salaam
Language
Ratings previous edition
Content is relevant to my practice
4.7
(185)
Content was free from commercial bias
4.5
Overall event experience
4.9